FDA REFORM LEGISLATION HOUSE VOTE TARGETED FOR WEEK OF SEPT. 29, STAFFER SAYS; DRAFT HOUSE DEVICE BILL ADDS SENATE LANGUAGE ON UNAPPROVED TREATMENTS
This article was originally published in The Gray Sheet
Executive Summary
FDA reform legislation is slated to be voted on by the House the week of Sept. 29 under a schedule outlined by House Commerce Committee staffers at a Sept. 12 briefing on Capitol Hill.